Stay updated on TEV-48125 SubQ in Chronic Migraine Prevention Clinical Trial
Sign up to get notified when there's something new on the TEV-48125 SubQ in Chronic Migraine Prevention Clinical Trial page.

Latest updates to the TEV-48125 SubQ in Chronic Migraine Prevention Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding the efficacy and safety of TEV-48125 for chronic migraine treatment, and the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference14%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to TEV-48125 SubQ in Chronic Migraine Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TEV-48125 SubQ in Chronic Migraine Prevention Clinical Trial page.